Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Gardner

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Biomedical Instrumentation & Technology|April 7, 2005
NFPA 99-an overview and discussion of recent changesThomas W Gardner,
JAMA Ophthalmology|June 25, 2026
Diabetic Retinal Disease Beginning in ChildhoodThomas W Gardner
Nature Medicine|February 8, 2024
Rejuvenation of diabetic macular edema with senolytic therapyTomoaki Murakami, Thomas W Gardner
Diabetes|October 21, 2024
Dissecting the Neurovascular Unit in Human Diabetic Retinal DiseaseThomas W Gardner, Toke Bek
Ophthalmology|December 13, 2006
Ruboxistaurin for diabetic retinopathyThomas W Gardner, David A Antonetti
Current Medicinal Chemistry|June 11, 2013
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implicationsMaxwell S Stem, Thomas W Gardner
Developments in Ophthalmology|October 27, 2015
Diabetic Retinopathy and Diabetic Macular EdemaSteven R Cohen, Thomas W Gardner
Vision Research|April 26, 2017
A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotypingThomas W Gardner, Jeffrey M Sundstrom
Nature Medicine|February 10, 2007
A prize catch for diabetic retinopathyThomas W Gardner, David A Antonetti
Current Diabetes Reports|October 14, 2015
Retinal Failure in Diabetes: a Feature of Retinal Sensory NeuropathyEllyn J Gray, Thomas W Gardner
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Biomedical Instrumentation & Technology|April 7, 2005
NFPA 99-an overview and discussion of recent changesThomas W Gardner,
JAMA Ophthalmology|June 25, 2026
Diabetic Retinal Disease Beginning in ChildhoodThomas W Gardner
Nature Medicine|February 8, 2024
Rejuvenation of diabetic macular edema with senolytic therapyTomoaki Murakami, Thomas W Gardner
Diabetes|October 21, 2024
Dissecting the Neurovascular Unit in Human Diabetic Retinal DiseaseThomas W Gardner, Toke Bek
Ophthalmology|December 13, 2006
Ruboxistaurin for diabetic retinopathyThomas W Gardner, David A Antonetti
Current Medicinal Chemistry|June 11, 2013
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implicationsMaxwell S Stem, Thomas W Gardner
Developments in Ophthalmology|October 27, 2015
Diabetic Retinopathy and Diabetic Macular EdemaSteven R Cohen, Thomas W Gardner
Vision Research|April 26, 2017
A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotypingThomas W Gardner, Jeffrey M Sundstrom
Nature Medicine|February 10, 2007
A prize catch for diabetic retinopathyThomas W Gardner, David A Antonetti
Current Diabetes Reports|October 14, 2015
Retinal Failure in Diabetes: a Feature of Retinal Sensory NeuropathyEllyn J Gray, Thomas W Gardner
Pageof 14